| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.78M | — |
| Operating expense | — | — |
| Net income | -72.94M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FDMT returned +123.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +111.1% |
| 1 year | +123.3% |
| 5 years | -48.2% |
| All-time high | $43.38 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FDMT would be worth today ›No. 4D Molecular Therapeutics, Inc. has not paid a dividend in the past 12 months.
4D Molecular Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol FDMT.
4D Molecular Therapeutics, Inc. is part of the Healthcare sector.
4D Molecular Therapeutics, Inc. has a market cap of 874.52M USD, based on the latest quote.
4D Molecular Therapeutics, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
